SCHEMBL7937979

SCHEMBL7937979

O=Cc1nc2ccc(F)cc2nc1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.53
KMT2A Q03164 1/20 0.43
NPC1 O15118 1/20 0.35
TP53 P04637 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
MAPK1 P28482 1/20 0.35
CASP1 P29466 1/20 0.35
CYP2C19 P33261 1/20 0.35
RAB9A P51151 1/20 0.35
MAPK10 P53779 1/20 0.35
CASP7 P55210 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ERN1 O75460 2/20 0.34
IDO1 P14902 1/20 0.34
TDO2 P48775 1/20 0.34
BACE1 P56817 1/20 0.33
PARP1 P09874 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12638660 1.00 KDM4E (0.53) KDM4EKMT2ANPC1TP53CYP1A2
SCHEMBL10851061 0.81 KDM4E (0.69) KDM4EKMT2ANPC1TP53CYP1A2
SCHEMBL2023290 0.79 KDM4E (0.44) KDM4EKMT2ANPC1TP53CYP1A2
SCHEMBL2052776 0.79 KDM4E (0.44) KDM4EKMT2ANPC1TP53CYP1A2
SCHEMBL5101956 0.77 MAPT (0.44) KDM4EKMT2ANPC1MAPTRAB9A
SCHEMBL2021348 0.76 NPC1 (0.43) KDM4EKMT2ANPC1MAPTRAB9A
SCHEMBL7937796 0.76 KDM4E (0.41) KDM4EKMT2ANPC1TP53CYP1A2
SCHEMBL12637535 0.76 TRIM24 (0.54) KDM4EKMT2ANPC1TP53CYP1A2
SCHEMBL12637539 0.76 TRIM24 (0.54) KDM4EKMT2ANPC1TP53CYP1A2
SCHEMBL27171556 0.74 ERN1 (0.43) KDM4ECYP1A2CYP3A4CYP2C19ERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010027097-A1 TRI-SUBSTITUTED PYRIMIDINE COMPOUNDS AND THEIR USE AS PDE10 INHIBITORS MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-03-11 WO disclosed